Extramedullary plasmacytoma is a plasma cell tumor that develops outside the bone marrow. These plasmacytomas commonly occur in the head and neck region, particularly in the upper respiratory and digestive tract. However, they can occur anywhere in the soft tissue of the body.
Doctors sometimes refer to extramedullary plasmacytoma (EMP) as solitary extramedullary plasmacytomas. Another name for the condition is solitary extraosseous plasmacytoma.
EMP is one of the two main types of solitary plasmacytoma that can occur in people. The other is called solitary bone plasmacytoma — in which case, the tumor develops in the bone.
Plasmacytomas are very
Keep reading to learn more about extramedullary plasmacytoma, including its causes, symptoms, treatment, and prognosis.
A plasmacytoma is a type of plasma cell neoplasm, which refers to an atypical tissue mass that can lead to cancer. These masses can develop when the plasma cells grow and divide uncontrollably, leading to an accumulation of cells in the soft tissues of the body.
The plasma cells also produce an antibody called a monoclonal protein or M protein. This is an antibody that is not useful in the body and does not help fight infection.
In EMP, a single plasma cell tumor grows in the soft tissue, mainly in the head and neck region. The tumor does not grow in bone or bone marrow.
About 80–90% of EMPs develop in the upper respiratory and digestive tracts. They can also develop in the bladder, lymph nodes, lungs, or other organs. However, the tumor can grow in soft tissue anywhere in the body.
Some people with EMP might develop a rare condition called multiple myeloma. This is when atypical plasma cells lead to the development of many tumors in the bone marrow.
- The overall incidence rate of extramedullary plasmacytoma was 0.09 adults in every 100,000.
- The death rate for myeloma was 4.77 people in every 100,000. This figure included people with extramedullary plasmacytoma and multiple myeloma.
- The highest incidence rates of extramedullary plasmacytoma, solitary plasmacytoma, and multiple myeloma were observable among non‐Hispanic black people compared with non-Hispanic white people. This difference may in part be due to genetic differences among both groups.
- There could be a link between multiple myeloma and excess body weight.
- People who were 80 years old or older had the highest rates of developing all three plasma neoplasms.
Scientists do not exactly know why some people develop extramedullary plasmacytoma. Some believe that certain factors, such as genetic disorders, viral infections, and exposure to high volumes of radiation, may
Plasma cells develop from B lymphocytes, a type of white blood cell that the bone marrow produces. When invading bacteria or viruses enter the body of a healthy person, some of their B lymphocytes turn into plasma cells. The plasma cells make antibodies to fight the invaders and stop infection and disease.
In the case of plasma cell neoplasms, the process becomes unregulated and can lead to the development of benign or malignant tumors in the bones or soft tissues.
An extramedullary plasmacytoma can
For example, if it grows in the person’s throat, they may experience difficulty swallowing.
People with extramedullary plasmacytoma may receive a combination of therapies to manage their condition. These can
- Surgery: This involves removing the tumor and may require additional treatment, which is known as adjuvant therapy, such as radiation therapy.
- Radiation therapy: Healthcare professionals direct this therapy at the tumor and nearby lymph nodes. It involves treatment with high-energy X-rays or other types of radiation.
- Chemotherapy: If the tumor grows or causes symptoms, a person may require drug treatment. Doctors can administer drugs by mouth or an injection into the veins or muscle, so that the medication can enter the bloodstream and reach the tumor.
People receive radiation therapy, chemotherapy, or both, to kill the atypical cells or stop them from dividing.
Like EMP, multiple myeloma is also a type of plasma cell neoplasm.
In multiple myeloma, the tumors are in the bone marrow and spread throughout the body. In contrast, with EMP, the tumors are confined to a single site in the soft tissue. Additionally, EMP is a
According to the
Due to the low number of reported cases of EMP and variations in response to the disease, it is
EMP involves the development of a tumor in the soft tissue, and it usually develops in the nose, throat, or tonsils. While EMP is a type of plasma cell neoplasm, it rarely occurs in people.
The exact symptoms of the disease depend on where the tumor forms. It is typically treatable with surgery, radiation therapy, chemotherapy, or a combination of these treatments.